当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Philippe Michel
The field of joint replacement has witnessed significant advancements with the emergence of tissue engineering. Traditional joint replacement methods often face challenges related to suboptimal functionality, implant integration, and long-term durability. Tissue-engineered joint implants have emerged as a transformative solution, harnessing biomimicry, enhanced biocompatibility, and regenerative potential to optimize functionality. These implants replicate the intricate architecture of native joints, promoting even load distribution and reducing implant-related complications. Through personalized designs based on patient anatomy, tissue-engineered implants achieve optimal fit and stability. Moreover, the potential for tissue regeneration and self-healing further enhances implant longevity. This article explores the scientific principles, benefits, and challenges of tissue-engineered joint implants, highlighting their potential to redefine joint replacement by providing patients with implants that prioritize both form and function.